Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Miriam T. Kastlmeier"'
Autor:
Miriam T. Kastlmeier, Erika Gonzalez-Rodriguez, Phoebe Cabanis, Eva M. Guenther, Ann-Christine König, Lianyong Han, Stefanie M. Hauck, Fenja See, Sara Asgharpour, Christina Bukas, Gerald Burgstaller, Marie Piraud, Mareike Lehmann, Rudolf A. Hatz, Jürgen Behr, Tobias Stoeger, Anne Hilgendorff, Carola Voss
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionInterstitial lung disease (ILD) is a heterogenous group of lung disorders where destruction and incomplete regeneration of the lung parenchyma often results in persistent architectural distortion of the pulmonary scaffold. Continuous mese
Externí odkaz:
https://doaj.org/article/5bf9ea6ed1794e0b87a4a953658f0383
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 24, p 15666 (2022)
Lung epithelial organoids for the hazard assessment of inhaled nanomaterials offer a promising improvement to in vitro culture systems used so far. Organoids grow in three-dimensional (3D) spheres and can be derived from either induced pluripotent st
Externí odkaz:
https://doaj.org/article/d69c4b250c744951be67fbd91a4ef829
Autor:
Miriam T. Kastlmeier, Erika Gonzalez Rodriguez, Phoebe Cabanis, Eva M. Guenther, Ann-Christine König, Lianyong Han, Stefanie M. Hauck, Fenja See, Sara Asgharpour, Christina Bukas, Gerald Burgstaller, Marie Piraud, Mareike Lehmann, Rudolf A. Hatz, Jürgen Behr, Tobias Stoeger, Anne Hilgendorff, Carola Voss
Interstitial lung disease (ILD) is a heterogenous group of lung disorders where destruction and incomplete regeneration of the lung parenchyma often results in persistent architectural distortion of the pulmonary scaffold. Continuous mesenchyme-cente
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::40a5f1837104823c81a938cd580fb7a5
https://doi.org/10.1101/2022.12.20.521114
https://doi.org/10.1101/2022.12.20.521114
Autor:
Michelle Plummer, Miriam T Kastlmeier, Renate Effner, Anna Pertek, Riccardo Berutti, Tobias Stoeger, Ellen D. Renner, Thomas Meitinger, Amina Sayed, Ejona Rusha, Florian Giesert, Thomas Volz, Beate Hagl, Carola Voss, Micha Drukker, Andreas C. Eberherr, Elisabeth Graf, Christine Wolf, Tim M. Strom, Andre Maaske, Alena Buyx
Publikováno v:
Web of Science
STAT3-hyper IgE syndrome (STAT3-HIES) is a primary immunodeficiency presenting with destructive lung disease along with other symptoms. CRISPR-Cas9-mediated adenine base editors (ABEs) have the potential to correct one of the most common STAT3-HIES c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9aa792d2aaac9b551bf0d31e2821e6eb
https://doi.org/10.1089/crispr.2020.0111
https://doi.org/10.1089/crispr.2020.0111